Redhill Biopharma
RDHL
1,28 €
Share price
-9.20%
Change (1 day)
-85.90%
Change (1 year)
Categories
Market capitalization of Redhill Biopharma (RDHL)
Market cap: €2.94 Million
As of July 2025 Redhill Biopharma has a market cap of €2.94 Million. This makes Redhill Biopharma the world's 10436th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Redhill Biopharma from 2013 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €2.94 M | -65.42% |
| 2024 | €8.5 M | -67.28% |
| 2023 | €25.98 M | 117.83% |
| 2022 | €11.92 M | -90.01% |
| 2021 | €0.11 B | -51.79% |
| 2020 | €0.24 B | 29.57% |
| 2019 | €0.19 B | 38.86% |
| 2018 | €0.13 B | 51.02% |
| 2017 | €91.13 M | -46.28% |
| 2016 | €0.16 B | 13.29% |
| 2015 | €0.14 B | 55.45% |
| 2014 | €96.32 M | 75.05% |
| 2013 | €55.02 M |
End of Day market cap according to different sources
On Jul 29th, 2025 the market cap of Redhill Biopharma was reported to be:
€2.93 Million
€2.94 Million
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | €105.12 B | 3,574,927.99% | 🇫🇷 France |
 Merck MRK | €179.60 B | 6,107,645.41% | 🇺🇸 USA |
 GlaxoSmithKline GSK | €66.11 B | 2,248,410.18% | 🇬🇧 UK |
 Taro Pharmaceutical TARO | €1.39 B | 47,440.81% | 🇮🇱 Israel |
 Teva Pharmaceutical Industries TEVA | €16.63 B | 565,743.68% | 🇮🇱 Israel |